Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Peled

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitisTali Lanton, Anat Shriki, Yael Nechemia-Arbely, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34<sup>+</sup> Cells in Healthy VolunteersMichal Abraham, Yaron Pereg, Baruch Bulvik, et al.
Cancer Research|June 12, 2021
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress TumorigenesisAnat Shriki, Tali Lanton, Amir Sonnenblick, et al.
Hepatology (Baltimore, Md.)|February 21, 2013
Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesisTamara Potikha, Evgeniy Stoyanov, Orit Pappo, et al.
Plos Biology|March 4, 2021
CD74 is a regulator of hematopoietic stem cell maintenanceShirly Becker-Herman, Milena Rozenberg, Carmit Hillel-Karniel, et al.
European Journal of Immunology|March 30, 2004
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virusOri Wald, Orit Pappo, Rifaat Safadi, et al.
Cancer Research|December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 PathwaysShiri Klein, Michal Abraham, Baruch Bulvik, et al.
Plos One|August 20, 2009
The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancersMerav Darash-Yahana, John W Gillespie, Stephen M Hewitt, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitisTali Lanton, Anat Shriki, Yael Nechemia-Arbely, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34<sup>+</sup> Cells in Healthy VolunteersMichal Abraham, Yaron Pereg, Baruch Bulvik, et al.
Cancer Research|June 12, 2021
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress TumorigenesisAnat Shriki, Tali Lanton, Amir Sonnenblick, et al.
Hepatology (Baltimore, Md.)|February 21, 2013
Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesisTamara Potikha, Evgeniy Stoyanov, Orit Pappo, et al.
Plos Biology|March 4, 2021
CD74 is a regulator of hematopoietic stem cell maintenanceShirly Becker-Herman, Milena Rozenberg, Carmit Hillel-Karniel, et al.
European Journal of Immunology|March 30, 2004
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virusOri Wald, Orit Pappo, Rifaat Safadi, et al.
Cancer Research|December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 PathwaysShiri Klein, Michal Abraham, Baruch Bulvik, et al.
Plos One|August 20, 2009
The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancersMerav Darash-Yahana, John W Gillespie, Stephen M Hewitt, et al.
Pageof 9